These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22785439)

  • 21. Pharmacological approaches to feeding behaviour and eating disorders.
    Willner P; Bergman J; Vanderschuren L
    Behav Pharmacol; 2012 Sep; 23(5-6):439-40. PubMed ID: 22854303
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of the endocannabinoid system in the regulation of energy expenditure.
    Cavuoto P; Wittert GA
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):79-86. PubMed ID: 19285262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
    Simon V; Cota D
    Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis.
    Oudin MJ; Hobbs C; Doherty P
    Eur J Neurosci; 2011 Nov; 34(10):1634-46. PubMed ID: 22103420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological modulation of the appetite].
    Cuerda Compés M; Bretón Lesmes I; Camblor Alvarez M; García Peris P
    Nutr Hosp; 1998; 13(2):69-75. PubMed ID: 9644944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
    Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
    Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocannabinoid system in cancer cachexia.
    Osei-Hyiaman D
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):443-8. PubMed ID: 17563462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.
    Heyman E; Gamelin FX; Aucouturier J; Di Marzo V
    Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptors: where they are and what they do.
    Mackie K
    J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the endocannabinoid system in obesity.
    Engeli S
    J Neuroendocrinol; 2008 May; 20 Suppl 1():110-5. PubMed ID: 18426509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.
    Bermudez-Silva FJ; Cardinal P; Cota D
    J Psychopharmacol; 2012 Jan; 26(1):114-24. PubMed ID: 21824982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
    Jonsson KO; Holt S; Fowler CJ
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.
    Ishiguro H; Carpio O; Horiuchi Y; Shu A; Higuchi S; Schanz N; Benno R; Arinami T; Onaivi ES
    Synapse; 2010 Jan; 64(1):92-6. PubMed ID: 19768813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic models of the endocannabinoid system.
    Monory K; Lutz B
    Curr Top Behav Neurosci; 2009; 1():111-39. PubMed ID: 21104382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
    Kunos G; Osei-Hyiaman D
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1101-4. PubMed ID: 18292184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.
    Matias I; Di Marzo V
    J Endocrinol Invest; 2006; 29(3 Suppl):15-26. PubMed ID: 16751706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The polarised life of the endocannabinoid system in CNS development.
    Anavi-Goffer S; Mulder J
    Chembiochem; 2009 Jul; 10(10):1591-8. PubMed ID: 19533710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptors and cholecystokinin in feeding inhibition.
    Alén F; Ramírez-López MT; Gómez de Heras R; Rodríguez de Fonseca F; Orio L
    Vitam Horm; 2013; 92():165-96. PubMed ID: 23601425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids and obesity.
    Chen G; Pang Z
    Vitam Horm; 2013; 91():325-68. PubMed ID: 23374723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat to treat fat: emerging relationship between dietary PUFA, endocannabinoids, and obesity.
    Kim J; Li Y; Watkins BA
    Prostaglandins Other Lipid Mediat; 2013; 104-105():32-41. PubMed ID: 23466458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.